Valneva Net Income vs Begin Period Cash Flow Analysis

VALN Stock

USD 4.42 0.25 5.35%

Valneva SE financial indicator trend analysis is much more than just breaking down Valneva SE ADR prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Valneva SE ADR is a good investment. Please check the relationship between Valneva SE Net Income and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Income vs Begin Period Cash Flow

Net Income vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Valneva SE ADR Net Income account and Begin Period Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Valneva SE's Net Income and Begin Period Cash Flow is -0.91. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Valneva SE ADR, assuming nothing else is changed. The correlation between historical values of Valneva SE's Net Income and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Valneva SE ADR are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Income i.e., Valneva SE's Net Income and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.91

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Valneva SE ADR financial statement analysis. It represents the amount of money remaining after all of Valneva SE ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Valneva SE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Valneva SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

As of the 22nd of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.35, while Selling General Administrative is likely to drop about 24.6 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	221.6M	150.3M	134.9M	141.7M
Cost Of Revenue	187.9M	324.4M	100.9M	58.6M

Total Operating Expenses Cost Of Revenue

Valneva SE fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue
Total Assets		0.61	0.89	0.94	0.75	0.83	-0.7	-0.64	0.73	0.96	0.84	0.43	0.95	0.66	0.65	-0.47	0.86	0.89	0.71	0.94	0.87	0.98	0.37	-0.01	0.7	0.72
Short Long Term Debt Total	0.61		0.49	0.63	0.56	0.88	0.05	-0.95	0.78	0.5	0.66	0.75	0.49	0.85	0.94	-0.57	0.76	0.78	0.94	0.7	0.82	0.54	0.9	-0.01	0.94	0.15
Other Current Liab	0.89	0.49		0.96	0.54	0.83	-0.76	-0.59	0.55	0.91	0.6	0.19	0.92	0.43	0.5	-0.24	0.79	0.82	0.62	0.92	0.89	0.93	0.3	-0.28	0.56	0.68
Total Current Liabilities	0.94	0.63	0.96		0.58	0.89	-0.73	-0.71	0.75	0.96	0.65	0.31	0.97	0.59	0.65	-0.36	0.88	0.94	0.73	0.98	0.93	0.97	0.44	-0.26	0.7	0.71
Total Stockholder Equity	0.75	0.56	0.54	0.58		0.61	-0.33	-0.5	0.42	0.63	0.87	0.5	0.61	0.69	0.62	-0.56	0.49	0.6	0.71	0.56	0.6	0.64	0.45	0.41	0.7	0.23
Property Plant And Equipment Net	0.83	0.88	0.83	0.89	0.61		-0.37	-0.92	0.79	0.79	0.7	0.55	0.78	0.75	0.86	-0.45	0.89	0.91	0.91	0.91	0.99	0.81	0.71	-0.21	0.88	0.42
Net Debt	-0.7	0.05	-0.76	-0.73	-0.33	-0.37		0.1	-0.35	-0.83	-0.31	0.21	-0.84	-0.1	-0.06	0.04	-0.46	-0.55	-0.13	-0.65	-0.45	-0.79	0.22	0.27	-0.14	-0.78
Retained Earnings	-0.64	-0.95	-0.59	-0.71	-0.5	-0.92	0.1		-0.78	-0.6	-0.55	-0.58	-0.59	-0.8	-0.93	0.47	-0.74	-0.8	-0.95	-0.73	-0.87	-0.62	-0.88	0.29	-0.94	-0.17
Accounts Payable	0.73	0.78	0.55	0.75	0.42	0.79	-0.35	-0.78		0.72	0.58	0.64	0.71	0.8	0.81	-0.48	0.87	0.85	0.73	0.82	0.76	0.72	0.56	-0.16	0.81	0.58
Cash	0.96	0.5	0.91	0.96	0.63	0.79	-0.83	-0.6	0.72		0.67	0.24	1.0	0.56	0.57	-0.37	0.81	0.9	0.63	0.93	0.83	0.99	0.3	-0.21	0.63	0.75
Non Current Assets Total	0.84	0.66	0.6	0.65	0.87	0.7	-0.31	-0.55	0.58	0.67		0.67	0.65	0.69	0.64	-0.58	0.72	0.68	0.7	0.71	0.7	0.71	0.42	0.46	0.68	0.45
Non Currrent Assets Other	0.43	0.75	0.19	0.31	0.5	0.55	0.21	-0.58	0.64	0.24	0.67		0.21	0.81	0.74	-0.61	0.65	0.41	0.66	0.46	0.52	0.3	0.56	0.41	0.7	0.25
Cash And Short Term Investments	0.95	0.49	0.92	0.97	0.61	0.78	-0.84	-0.59	0.71	1.0	0.65	0.21		0.53	0.55	-0.32	0.8	0.89	0.61	0.93	0.82	0.99	0.28	-0.23	0.61	0.75
Common Stock Total Equity	0.66	0.85	0.43	0.59	0.69	0.75	-0.1	-0.8	0.8	0.56	0.69	0.81	0.53		0.96	-0.71	0.72	0.68	0.87	0.66	0.71	0.59	0.71	0.07	0.94	0.31
Common Stock Shares Outstanding	0.65	0.94	0.5	0.65	0.62	0.86	-0.06	-0.93	0.81	0.57	0.64	0.74	0.55	0.96		-0.66	0.75	0.76	0.94	0.7	0.81	0.6	0.84	-0.09	0.99	0.22
Short Term Investments	-0.47	-0.57	-0.24	-0.36	-0.56	-0.45	0.04	0.47	-0.48	-0.37	-0.58	-0.61	-0.32	-0.71	-0.66		-0.47	-0.44	-0.57	-0.42	-0.43	-0.39	-0.45	-0.28	-0.63	-0.24
Non Current Liabilities Total	0.86	0.76	0.79	0.88	0.49	0.89	-0.46	-0.74	0.87	0.81	0.72	0.65	0.8	0.72	0.75	-0.47		0.88	0.73	0.96	0.91	0.84	0.47	-0.08	0.74	0.74
Other Current Assets	0.89	0.78	0.82	0.94	0.6	0.91	-0.55	-0.8	0.85	0.9	0.68	0.41	0.89	0.68	0.76	-0.44	0.88		0.8	0.94	0.9	0.9	0.6	-0.19	0.8	0.58
Other Stockholder Equity	0.71	0.94	0.62	0.73	0.71	0.91	-0.13	-0.95	0.73	0.63	0.7	0.66	0.61	0.87	0.94	-0.57	0.73	0.8		0.74	0.87	0.65	0.88	-0.05	0.97	0.19
Total Liab	0.94	0.7	0.92	0.98	0.56	0.91	-0.65	-0.73	0.82	0.93	0.71	0.46	0.93	0.66	0.7	-0.42	0.96	0.94	0.74		0.94	0.95	0.45	-0.19	0.73	0.75
Property Plant And Equipment Gross	0.87	0.82	0.89	0.93	0.6	0.99	-0.45	-0.87	0.76	0.83	0.7	0.52	0.82	0.71	0.81	-0.43	0.91	0.9	0.87	0.94		0.86	0.63	-0.21	0.83	0.52
Total Current Assets	0.98	0.54	0.93	0.97	0.64	0.81	-0.79	-0.62	0.72	0.99	0.71	0.3	0.99	0.59	0.6	-0.39	0.84	0.9	0.65	0.95	0.86		0.33	-0.19	0.65	0.76
Short Term Debt	0.37	0.9	0.3	0.44	0.45	0.71	0.22	-0.88	0.56	0.3	0.42	0.56	0.28	0.71	0.84	-0.45	0.47	0.6	0.88	0.45	0.63	0.33		-0.1	0.84	-0.14
Intangible Assets	-0.01	-0.01	-0.28	-0.26	0.41	-0.21	0.27	0.29	-0.16	-0.21	0.46	0.41	-0.23	0.07	-0.09	-0.28	-0.08	-0.19	-0.05	-0.19	-0.21	-0.19	-0.1		-0.07	-0.07
Common Stock	0.7	0.94	0.56	0.7	0.7	0.88	-0.14	-0.94	0.81	0.63	0.68	0.7	0.61	0.94	0.99	-0.63	0.74	0.8	0.97	0.73	0.83	0.65	0.84	-0.07		0.22
Current Deferred Revenue	0.72	0.15	0.68	0.71	0.23	0.42	-0.78	-0.17	0.58	0.75	0.45	0.25	0.75	0.31	0.22	-0.24	0.74	0.58	0.19	0.75	0.52	0.76	-0.14	-0.07	0.22

Click cells to compare fundamentals

Valneva SE Account Relationship Matchups

Valneva SE fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	264.7M	449.2M	817.4M	621.3M	460.1M	252.3M
Short Long Term Debt Total	85.2M	105.5M	114.7M	152.4M	208.8M	219.3M
Other Current Liab	27.0M	51.7M	342.6M	200.2M	93.7M	98.4M
Total Current Liabilities	41.3M	175.9M	369.0M	277.4M	158.9M	166.8M
Total Stockholder Equity	135.2M	77.4M	170.6M	219.8M	128.2M	97.2M
Property Plant And Equipment Net	69.3M	78.2M	173.8M	154.0M	156.6M	164.4M
Net Debt	20.8M	(98.9M)	(232.0M)	(137.0M)	82.7M	86.9M
Retained Earnings	(176.2M)	(233.5M)	(307.0M)	(450.3M)	(561.2M)	(533.1M)
Accounts Payable	8.9M	24.9M	16.0M	14.5M	17.6M	18.4M
Cash	64.4M	204.4M	346.6M	289.4M	126.1M	80.3M
Non Current Assets Total	135.6M	140.7M	231.5M	196.7M	206.6M	111.2M
Non Currrent Assets Other	17.2M	19.5M	19.3M	8.3M	25.6M	26.9M
Cash And Short Term Investments	64.4M	204.4M	346.6M	289.4M	126.1M	84.0M
Common Stock Shares Outstanding	91.7M	90.8M	97.6M	115.5M	138.6M	145.6M
Liabilities And Stockholders Equity	264.7M	449.2M	817.4M	621.3M	460.1M	252.3M
Non Current Liabilities Total	88.3M	195.9M	277.8M	124.2M	182.3M	191.4M
Other Current Assets	14.9M	57.8M	71.0M	76.2M	50.6M	53.2M
Other Stockholder Equity	249.7M	254.5M	461.8M	593.4M	593.4M	623.0M
Total Liab	129.6M	371.7M	646.8M	401.5M	331.8M	348.4M
Property Plant And Equipment Gross	69.3M	78.2M	215.3M	154.0M	156.6M	164.4M
Total Current Assets	129.2M	308.4M	585.8M	424.7M	262.8M	141.7M
Short Term Debt	4.3M	9.7M	10.2M	37.0M	47.0M	49.3M
Intangible Assets	41.8M	35.4M	32.7M	28.7M	24.3M	23.1M
Common Stock	13.6M	13.6M	15.8M	20.8M	20.8M	21.9M
Current Deferred Revenue	1.1M	89.6M	124.0M	9.4M	5.7M	5.4M
Net Receivables	24.0M	19.2M	44.0M	23.9M	41.6M	43.7M
Inventory	25.8M	26.9M	124.1M	35.1M	44.5M	28.5M
Accumulated Other Comprehensive Income	48.0M	52.3M	52.5M	55.3M	75.3M	79.0M
Other Assets	21.7M	24.1M	26.8M	(2K)	(9.3M)	(8.9M)
Other Liab	3.7M	7.4M	100.1M	173.4M	199.4M	209.4M
Net Tangible Assets	95.3M	43.8M	139.5M	192.5M	221.4M	113.3M
Long Term Debt	24.3M	46.4M	50.7M	87.2M	132.8M	139.4M
Capital Lease Obligations	58.9M	52.1M	56.8M	53.6M	32.0M	48.3M
Deferred Long Term Liab	2.0M	1.7M	1.6M	1.4M	1.3M	1.5M
Net Invested Capital	161.5M	130.8M	228.4M	318.6M	305.1M	228.7M
Short Long Term Debt	2.0M	7.0M	7.1M	11.6M	44.1M	46.3M
Non Current Liabilities Other	99K	97.3M	159.0M	6.8M	79K	75.1K
Net Working Capital	87.9M	132.6M	216.9M	147.3M	104.0M	128.4M

Pair Trading with Valneva SE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.

Moving together with Valneva Stock

0.84	VRAX	Virax Biolabs Group	Pair Corr
0.69	VRPX	Virpax Pharmaceuticals	Pair Corr
0.77	DYN	Dyne Therapeutics	Pair Corr

Moving against Valneva Stock

0.81	PRAX	Praxis Precision Med	Pair Corr
0.77	EWTX	Edgewise Therapeutics	Pair Corr
0.75	VRDN	Viridian Therapeutics	Pair Corr
0.74	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.67	AKRO	Akero Therapeutics	Pair Corr

The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE ADR to buy it.

The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Valneva SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Valneva SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Valneva Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Valneva Se Adr Stock:

How To Invest In Valneva

Details

Is Valneva Stock a good investment?

Details

What is Valneva SE's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.13)

Revenue Per Share

2.3

Quarterly Revenue Growth

0.204

Return On Assets

(0.11)

Return On Equity

(0.04)

The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Valneva Net Income vs Begin Period Cash Flow Analysis

Net Income vs Begin Period Cash Flow

Net Income vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Net Income

Begin Period Cash Flow

Valneva SE fundamental ratios Correlations

Valneva SE Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Valneva SE fundamental ratios Accounts

Pair Trading with Valneva SE

Moving together with Valneva Stock

Moving against Valneva Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Common Stock	+ 0.99	Common Stock Shares Outstanding
Total Current Assets	+ 0.98	Total Assets

Other Stockholder Equity	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Short Long Term Debt Total
Common Stock	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.93	Retained Earnings
Retained Earnings	- 0.92	Property Plant And Equipment Net
Short Term Debt	- 0.88	Retained Earnings